Octogenarians with AML Can Have Durable Remissions with Venetoclax and Hypomethylating Agent Therapy Despite Significant Dose Reductions
- Resource Type
- Article
- Source
- Blood; November 2021, Vol. 138 Issue: 1, Number 1 Supplement 1 p1259-1259, 1p
- Subject
- Language
- ISSN
- 00064971; 15280020